Growth Metrics

Neogenomics (NEO) Current Leases (2016 - 2025)

Historic Current Leases for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $4.8 million.

  • Neogenomics' Current Leases rose 4126.0% to $4.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.8 million, marking a year-over-year increase of 4126.0%. This contributed to the annual value of $4.8 million for FY2025, which is 4126.0% up from last year.
  • According to the latest figures from Q4 2025, Neogenomics' Current Leases is $4.8 million, which was up 4126.0% from $4.5 million recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Current Leases ranged from a high of $7.4 million in Q2 2023 and a low of $3.1 million during Q1 2025
  • Moreover, its 5-year median value for Current Leases was $5.6 million (2021), whereas its average is $5.3 million.
  • Its Current Leases has fluctuated over the past 5 years, first surged by 4864.92% in 2021, then crashed by 5140.06% in 2024.
  • Over the past 5 years, Neogenomics' Current Leases (Quarter) stood at $6.9 million in 2021, then decreased by 4.36% to $6.6 million in 2022, then dropped by 14.79% to $5.6 million in 2023, then tumbled by 39.73% to $3.4 million in 2024, then surged by 41.26% to $4.8 million in 2025.
  • Its Current Leases was $4.8 million in Q4 2025, compared to $4.5 million in Q3 2025 and $4.1 million in Q2 2025.